Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117072) titled 'Imaging study of positron radionuclide-labeled denatured collagen targeting probe in the diagnosis of pancreatic ductal adenocarcinoma' on Jan. 19.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Guangdong Provincial Hospital of Chinese Medicine (Guangdong Provincial Academic of Chinese Medicine Science; Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine)
Condition:
Suspected pancreatic ductal adenocarcinoma
Intervention:
Gold Standard:Lesion biopsy or surgical pathology
mpMRI and PET/CT (MR)
Recruitment Status: Recruiting
Phase: ...